Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2015
Total Assets: $167.38B
Liabilities Breakdown FY2015
Total Liabilities: $102.38B
Asset Breakdown
Total Assets: $167.38B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.64B | 2.2% |
| Accounts Receivable | $8.18B | 4.9% |
| Inventory | $7.51B | 4.5% |
| Property, Plant & Equipment | $13.77B | 8.2% |
| Goodwill | $48.24B | 28.8% |
| Intangible Assets | $40.36B | 24.1% |
| Other Assets | $45.69B | 27.3% |
Liabilities Breakdown
Total Liabilities: $102.38B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.62B | 3.5% |
| Long-Term Debt | $28.74B | 28.1% |
| Other Liabilities | $70.02B | 68.4% |